Scottish Development International, the economic development arm of the Scottish Executive, has organized a delegation of companies and universities from Scotland's life sciences sector to attend the Bio Korea 2008 conference and exhibition, the first event to be held at the Osong Bio-Health Science Technolpolis in the Chungbuk Province, South Korea.
Representatives from Scottish organizations, including Avanticell, Vitrology and the Scottish Centre for Regenerative Medicine, will travel to South Korea for the event. They will attend targeted business partnering sessions with some of Asia's largest pharmaceutical companies and speak in pre-arranged forums on a wide variety of subjects, including regenerative medicine, investment attraction and technology commercialization. The bio sector is now seen as the key growth industry in South Korea and its government is aiming to be the world's seventh largest biological market by 2016.
Tony Baker, director life sciences and chemicals at Scottish Development International, said: "during the current economic slowdown it is more important than ever for companies to explore new markets that exploit their strengths, and we are delighted that so many companies are making the trip to Bio Korea 2008."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze